Related references
Note: Only part of the references are listed.Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
Walter R. J. Taylor et al.
LANCET (2019)
The ethics of using placebo in randomised controlled trials: a case study of a Plasmodium vivax antirelapse trial
Phaik Yeong Cheah et al.
BMC MEDICAL ETHICS (2018)
Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens
Tesfay Abreha et al.
BMC INFECTIOUS DISEASES (2015)
Evaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant-reported adverse events and related data
Elizabeth N. Allen et al.
MALARIA JOURNAL (2013)
Reliability of adverse symptom event reporting by clinicians
Thomas M. Atkinson et al.
QUALITY OF LIFE RESEARCH (2012)
Individual Differences in the Subjective Experience of Pain: New Insights Into Mechanisms and Models
Robert C. Coghill
HEADACHE (2010)
Predictors of Spontaneous and Systematically Assessed Suicidal Adverse Events in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) Study
David A. Brent et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Monitoring antimalarial safety and tolerability in clinical trials: A case study from Uganda
Sarah G. Staedke et al.
MALARIA JOURNAL (2008)
Brief communication: Better ways to question patients about adverse medical events - A randomized, controlled trial
S Bent et al.
ANNALS OF INTERNAL MEDICINE (2006)
Share Paper
